Close relatives or distant cousins?

Lancet Oncology

Volumn 4, Issue 10, 2003, Pages 593-594

  Tutt, Andrew ^a,b   Ashworth, Alan ^b  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; COMPLEMENTARY DNA; CYTOKERATIN;

BONE MARROW BIOPSY; BONE MARROW CELL; BONE METASTASIS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER SURVIVAL; CELL CLONING; COMPARATIVE GENOMIC HYBRIDIZATION; DRUG EFFICACY; DRUG TARGETING; EPITHELIUM CELL; FEMALE; GENETIC ANALYSIS; GENETIC DIFFERENCE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIVER METASTASIS; LUNG METASTASIS; LYMPH NODE METASTASIS; NOTE; PHENOTYPE; PREDICTION; PRIORITY JOURNAL; RELATIVE; TUMOR CELL;

BONE NEOPLASMS; BREAST NEOPLASMS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; NEOPLASM METASTASIS;

EID: 0141997803     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(03)01217-8     Document Type: Letter

References (9)

1. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group. Lancet 1998; 352: 930-42.
2. Smith IE, Lipton L. Preoperative or neoadjuvant medical therapy for early breast cancer. Lancet Oncol 2001; 2: 561-70.
3. Kuukasjarvi T, Karhu R, Tanner M, et al. Genetic heterogeneity and clonal evolution underlying development of asynchronous metastasis in human breast cancer. Cancer Res 1997; 57: 1597-1604.
4. Pandis N, Teixeira MR, Adeyinka A, et al. Cytogenetic comparison of primary tumors and lymph node metastases in breast cancer patients. Genes Chromosomes Cancer 1998; 22: 122-29.
5. Braun S, Pantel K, Muller P, et al. Cytokeratin-positive cells in the bone marrow and survival of patients with stage I, II, or III breast cancer. N Engl J Med 2000; 342: 525-33.
6. Muller P, Weckermann D, Riethmuller G, and Schlimok G. Detection of genetic alterations in micrometastatic cells in bone marrow of cancer patients by fluorescence in situ hybridization. Cancer Genet Cytogenet 1996; 88: 8-16.
7. Schmidt-Kittler O, Ragg T, Daskalakis A, et al. From latent disseminated cells to overt metastasis: genetic analysis of systemic breast cancer progression. Proc Natl Acad Sci USA 2003; 100: 7737-42.
8. Buerger H, Otterbach F, Simon R, et al. Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways. J Pathol 1999; 187: 396-402.
9. Wolmark N, Wang J, Mamounas E, et al. Preoperative chemotherapy in patients with operable breast cancer: nine-year results from National Surgical Adjuvant Breast and Bowel Project B-18. J Natl Cancer Inst Monogr 2001; 30: 96-102.